• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人类白细胞抗原 (HLA) 的物质使用障碍风险评估。

Risk assessment of substance use disorders based on the human leukocyte antigen (HLA).

机构信息

The HLA Research Group, Brain Sciences Center (11B), Department of Veterans Affairs Health Care System, Minneapolis VAHCS, One Veterans Drive, Minneapolis, MN, 55417, USA.

Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.

出版信息

Sci Rep. 2023 May 26;13(1):8545. doi: 10.1038/s41598-023-35305-2.

DOI:10.1038/s41598-023-35305-2
PMID:37237010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10220069/
Abstract

Substance use disorders (SUDs) are common and costly conditions that are partially attributable to genetic factors. In light of immune system influences on neural and behavioral aspects of addiction, the present study evaluated the influence of genes involved in the human immune response, human leukocyte antigen (HLA), on SUDs. We used an immunogenetic epidemiological approach to evaluate associations between the population frequencies of 127 HLA alleles and the population prevalences of six SUDs (alcohol, amphetamine, cannabis, cocaine, opioid, and "other" dependence) in 14 countries of Continental Western Europe to identify immunogenetic profiles of each SUD and evaluate their associations. The findings revealed two primary groupings of SUDs based on their immunogenetic profiles: one group comprised cannabis and cocaine, whereas the other group comprised alcohol, amphetamines, opioids, and "other" dependence. Since each individual possesses 12 HLA alleles, the population HLA-SUD scores were subsequently used to estimate individual risk for each SUD. Overall, the findings highlight similarities and differences in immunogenetic profiles of SUDs that may influence the prevalence and co-occurrence of problematic SUDs and may contribute to assessment of SUD risk of an individual on the basis of their HLA genetic makeup.

摘要

物质使用障碍(SUD)是常见且代价高昂的疾病,部分归因于遗传因素。鉴于免疫系统对成瘾的神经和行为方面的影响,本研究评估了参与人类免疫反应的基因,即人类白细胞抗原(HLA),对 SUD 的影响。我们采用免疫遗传流行病学方法,评估了 127 种 HLA 等位基因在人群中的频率与六种 SUD(酒精、安非他命、大麻、可卡因、阿片类药物和“其他”依赖)在 14 个西欧大陆国家中的人群流行率之间的关联,以确定每种 SUD 的免疫遗传特征,并评估它们之间的关联。研究结果显示,基于免疫遗传特征,SUD 可分为两组:一组包括大麻和可卡因,另一组包括酒精、安非他命、阿片类药物和“其他”依赖。由于每个人都拥有 12 种 HLA 等位基因,因此随后使用人群 HLA-SUD 评分来估计每个人对每种 SUD 的风险。总体而言,研究结果突出了 SUD 的免疫遗传特征的相似性和差异性,这些特征可能会影响有问题的 SUD 的流行和共病发生,并有助于根据个体的 HLA 遗传构成来评估 SUD 风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/3fa90d5fec1c/41598_2023_35305_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/50a4118e3b03/41598_2023_35305_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/f0abd05a0ae7/41598_2023_35305_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/1793a7eb5e38/41598_2023_35305_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/3fa90d5fec1c/41598_2023_35305_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/50a4118e3b03/41598_2023_35305_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/f0abd05a0ae7/41598_2023_35305_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/1793a7eb5e38/41598_2023_35305_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccbd/10220069/3fa90d5fec1c/41598_2023_35305_Fig4_HTML.jpg

相似文献

1
Risk assessment of substance use disorders based on the human leukocyte antigen (HLA).基于人类白细胞抗原 (HLA) 的物质使用障碍风险评估。
Sci Rep. 2023 May 26;13(1):8545. doi: 10.1038/s41598-023-35305-2.
2
Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.青年期酒精及其他物质使用障碍的患病率及其相关因素:一项基于人群的研究。
BMC Psychiatry. 2009 Nov 19;9:73. doi: 10.1186/1471-244X-9-73.
3
Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders.美国有监禁史和物质使用障碍的成年人中成瘾治疗的利用情况。
Addict Sci Clin Pract. 2019 Mar 5;14(1):9. doi: 10.1186/s13722-019-0138-4.
4
Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration.美国退伍军人健康管理局中男性和女性的物质使用障碍与自杀死亡风险
Addiction. 2017 Jul;112(7):1193-1201. doi: 10.1111/add.13774. Epub 2017 Mar 16.
5
Genetics of substance use disorders: a review.物质使用障碍的遗传学:综述。
Psychol Med. 2021 Oct;51(13):2189-2200. doi: 10.1017/S0033291721000969. Epub 2021 Apr 21.
6
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.加拿大情绪与焦虑治疗网络(CANMAT)特别工作组关于情绪障碍合并物质使用障碍患者管理的建议。
Ann Clin Psychiatry. 2012 Feb;24(1):38-55.
7
Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample.在一个主要依赖物质的样本中,DSM-IV 和 DSM-5 酒精、可卡因、阿片类药物和大麻使用障碍的流行率。
Drug Alcohol Depend. 2013 Jan 1;127(1-3):215-9. doi: 10.1016/j.drugalcdep.2012.07.009. Epub 2012 Aug 9.
8
Immunogenetic Profiles and Associations of Breast, Cervical, Ovarian, and Uterine Cancers.乳腺癌、宫颈癌、卵巢癌和子宫癌的免疫遗传学特征及关联
Cancer Inform. 2023 Jan 16;22:11769351221148588. doi: 10.1177/11769351221148588. eCollection 2023.
9
Generalized genetic liability to substance use disorders.物质使用障碍的广义遗传易感性。
J Clin Invest. 2024 Jun 3;134(11):e172881. doi: 10.1172/JCI172881.
10
Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.物质使用障碍与2019冠状病毒病:对退伍军人健康管理局全国电子健康记录的分析
Drug Alcohol Depend. 2022 May 1;234:109383. doi: 10.1016/j.drugalcdep.2022.109383. Epub 2022 Mar 3.

本文引用的文献

1
Cannabidiol and substance use disorder: Dream or reality.大麻二酚与物质使用障碍:梦想还是现实。
Neuropharmacology. 2022 Apr 1;207:108948. doi: 10.1016/j.neuropharm.2022.108948. Epub 2022 Jan 13.
2
Genetics of substance use disorders: a review.物质使用障碍的遗传学:综述。
Psychol Med. 2021 Oct;51(13):2189-2200. doi: 10.1017/S0033291721000969. Epub 2021 Apr 21.
3
Molecular genetics of substance use disorders: An umbrella review.物质使用障碍的分子遗传学:伞式综述。
Neurosci Biobehav Rev. 2021 May;124:358-369. doi: 10.1016/j.neubiorev.2021.01.019. Epub 2021 Feb 5.
4
Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context.在全球大流行背景下,了解人类白细胞抗原系统对常见重大精神疾病的遗传贡献。
Brain Behav Immun. 2021 Jan;91:731-739. doi: 10.1016/j.bbi.2020.09.033. Epub 2020 Oct 5.
5
Current status of immunotherapies for addiction.成瘾的免疫疗法现状。
Ann N Y Acad Sci. 2021 Apr;1489(1):3-16. doi: 10.1111/nyas.14329. Epub 2020 Mar 8.
6
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.1990 - 2016年195个国家和地区因酒精和药物使用所致的全球疾病负担:全球疾病负担研究2016的系统分析
Lancet Psychiatry. 2018 Dec;5(12):987-1012. doi: 10.1016/S2215-0366(18)30337-7. Epub 2018 Nov 1.
7
MHC class I in dopaminergic neurons suppresses relapse to reward seeking.多巴胺能神经元中的 MHC Ⅰ类分子抑制觅药行为复发。
Sci Adv. 2018 Mar 14;4(3):eaap7388. doi: 10.1126/sciadv.aap7388. eCollection 2018 Mar.
8
HLA variation and disease.人类白细胞抗原(HLA)变异与疾病。
Nat Rev Immunol. 2018 May;18(5):325-339. doi: 10.1038/nri.2017.143. Epub 2018 Jan 2.
9
Genome-wide meta-analysis of copy number variations with alcohol dependence.酒精依赖相关拷贝数变异的全基因组荟萃分析。
Pharmacogenomics J. 2018 May 22;18(3):398-405. doi: 10.1038/tpj.2017.35. Epub 2017 Jul 11.
10
An Exploratory Association Study of Alcohol Use Disorder and DNA Methylation.酒精使用障碍与DNA甲基化的探索性关联研究
Alcohol Clin Exp Res. 2016 Aug;40(8):1633-40. doi: 10.1111/acer.13138. Epub 2016 Jul 8.